Chondrodysplasia-difference of sex development syndrome

Chondrodysplasia-difference of sex development syndrome (also known as chondrodysplasia-sex reversal syndrome or campomelic dysplasia-related conditions) is an extremely rare congenital disorder characterized by the combination of skeletal abnormalities (chondrodysplasia) and differences of sex development (DSD). This condition primarily affects the skeletal system and reproductive/gonadal development. Affected individuals typically present with skeletal features including shortening and bowing of long bones, abnormalities of the spine and ribcage, and other cartilage and bone malformations. Individuals with a 46,XY karyotype may present with ambiguous genitalia or female-appearing external genitalia, reflecting a disorder of gonadal development. Additional features may include facial dysmorphism, respiratory difficulties due to thoracic abnormalities, and joint anomalies. This syndrome overlaps clinically with campomelic dysplasia, which is caused by mutations in or near the SOX9 gene on chromosome 17. SOX9 plays a critical role in both cartilage formation and male sex determination, explaining the co-occurrence of skeletal and sex development anomalies. The severity of skeletal involvement can vary, ranging from severe neonatal presentations with life-threatening respiratory compromise to milder forms. Management is supportive and multidisciplinary, involving orthopedic care for skeletal complications, respiratory support when needed, endocrinological evaluation and management of differences of sex development, and psychosocial support. There is currently no curative treatment, and care focuses on addressing individual symptoms and improving quality of life. Genetic counseling is recommended for affected families.

Common questions about Chondrodysplasia-difference of sex development syndrome